Microbix Biosystems (TSE:MBX) Shares Cross Above 50-Day Moving Average – Time to Sell?

Shares of Microbix Biosystems Inc. (TSE:MBX) crossed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of C$0.30 and traded as high as C$0.30. Microbix Biosystems shares last traded at C$0.29, with a volume of 24,836 shares trading hands.

Microbix Biosystems Trading Down 1.7%

The company has a quick ratio of 5.57, a current ratio of 6.89 and a debt-to-equity ratio of 27.69. The company has a 50-day moving average price of C$0.30 and a 200-day moving average price of C$0.27. The company has a market capitalization of C$39.72 million, a price-to-earnings ratio of -8.06 and a beta of 0.72.

Microbix Biosystems (TSE:MBX) last announced its earnings results on Thursday, August 13th. The company reported C($0.01) earnings per share for the quarter. Microbix Biosystems had a negative net margin of 31.72% and a negative return on equity of 18.83%. The business had revenue of C$4.06 million for the quarter. Research analysts predict that Microbix Biosystems Inc. will post 0.02 EPS for the current fiscal year.

About Microbix Biosystems

Microbix Biosystems Inc creates proprietary biological products for human health, with over 120 skilled employees and revenues of C$ 18.6 million in its last reported fiscal year (2025). It enables the worldwide commercialization of diagnostic assays by making a wide range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs ¿ ) and reference materials (QUANTDx ¿ ) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows.